Publications by authors named "S M J G Steyaert"

Article Synopsis
  • A study looked at 161 samples of bacteria from different sources, including people with cystic fibrosis, and found that only 39% could be identified with confidence using a special technology called MALDI-TOF MS.
  • By analyzing some of the samples’ entire DNA, researchers discovered seven new types of bacteria and updated the identification database, boosting the identification success rate to 77%.
  • The new bacteria were mostly resistant to many medicines but did respond well to a few specific antibiotics, which is important for treating infections.
View Article and Find Full Text PDF

BackgroundAntimicrobial resistance (AMR) of (MG) is a growing concern worldwide and surveillance is needed. In Belgium, samples are sent to the National Reference Centre of Sexually Transmitted Infections (NRC-STI) on a voluntary basis and representative or robust national AMR data are lacking.AimWe aimed to estimate the occurrence of resistant MG in Belgium.

View Article and Find Full Text PDF

Ruminants are dependent on their gut microbiomes for nutrient extraction from plant diets. However, knowledge about the composition, diversity, function, and spatial structure of gut microbiomes, especially in wild ruminants, is limited, largely because analysis has been restricted to faeces or the rumen. In two geographically separated reindeer subspecies, 16S rRNA gene amplicon sequencing revealed strong spatial structuring, and pronounced differences in microbial diversity of at least 33 phyla across the stomach, small intestine, and large intestine (including faeces).

View Article and Find Full Text PDF

Technological advances now make it possible to study a patient from multiple angles with high-dimensional, high-throughput multi-scale biomedical data. In oncology, massive amounts of data are being generated ranging from molecular, histopathology, radiology to clinical records. The introduction of deep learning has significantly advanced the analysis of biomedical data.

View Article and Find Full Text PDF

Introduction: We conducted a 3-month, prospective study in a population of patients with Myasthenia Gravis (MG), utilizing a fully decentralized approach for recruitment and monitoring (ClinicalTrials.gov Identifier: NCT04590716). The study objectives were to assess the feasibility of collecting real-world data through a smartphone-based research platform, in order to characterize symptom involvement during MG exacerbations.

View Article and Find Full Text PDF